These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6377294)

  • 21. [Intensified insulin therapy in children and adolescents with labile diabetes mellitus].
    Lebedev NB; Shcherbacheva LN; Kniazeva AP; Lobanova AM
    Pediatriia; 1989; (11):75-9. PubMed ID: 2691980
    [No Abstract]   [Full Text] [Related]  

  • 22. Insulin therapy for diabetes mellitus: treatment regimens and associated costs.
    Charbonnel B; Penfornis A; Varroud-Vial M; Kusnik-Joinville O; Detournay B
    Diabetes Metab; 2012 Apr; 38(2):156-63. PubMed ID: 22172400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Ultratard HM, a new human insulin. Advantages as compared to current preparations?].
    Saner B; Fankhauser S
    Schweiz Med Wochenschr; 1986 Jan; 116(4):116-9. PubMed ID: 3513303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Basal insulin analogues in the management of diabetes mellitus: What progress have we made?
    Owens DR; Matfin G; Monnier L
    Diabetes Metab Res Rev; 2014 Feb; 30(2):104-19. PubMed ID: 24026961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prolonged efficacy of short acting insulin Lispro in combination with human ultralente in insulin-dependent diabetes mellitus.
    Burge MR; Waters DL; Holcombe JH; Schade DS
    J Clin Endocrinol Metab; 1997 Mar; 82(3):920-4. PubMed ID: 9062507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diurnal blood and urine glucose and acetone bodies in labile juvenile diabetics on one- and two-injection insulin therapy.
    Akerblom HK; Hiekkala H
    Diabetologia; 1970 Apr; 6(2):130-4. PubMed ID: 5422442
    [No Abstract]   [Full Text] [Related]  

  • 27. Long term use of intravenous insulin because of failure of subcutaneous insulin treatment.
    Diaz-Pereda L; Yang TI; Knowles HC
    Trans Am Clin Climatol Assoc; 1979; 90():102-8. PubMed ID: 516224
    [No Abstract]   [Full Text] [Related]  

  • 28. [Association of zinc-mixed insulin with a new rapid acting ordinary insulin. Experimental study in the treatment of infantile diabetes].
    Chaptal J; Jean R; Gillaumot R; Morel G
    Pathol Biol; 1965; 13(11):622-9. PubMed ID: 5321079
    [No Abstract]   [Full Text] [Related]  

  • 29. [Combinations of insulin preparations: one or the other].
    van der Meer J
    Ned Tijdschr Geneeskd; 1986 Jun; 130(24):1092-4. PubMed ID: 3523262
    [No Abstract]   [Full Text] [Related]  

  • 30. [A 50-year history of new drugs in Japan-the development and progress of anti-diabetic drugs and the epidemiological aspects of diabetes mellitus].
    Ozawa H; Murai Y; Ozawa T
    Yakushigaku Zasshi; 2003; 38(1):11-27. PubMed ID: 14570054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Injection of acidic or neutral insulin and pain: a single-center, prospective, controlled, noninterventional study in pediatric patients with type 1 diabetes mellitus.
    Karges B; Muche R; Riegger I; Moritz M; Heinze E; Debatin KM; Wabitsch M; Karges W
    Clin Ther; 2006 Dec; 28(12):2094-101. PubMed ID: 17296465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The management of brittle diabetes mellitus in children.
    Rosenbloom AL
    South Med J; 1971 Jun; 64(6):729-33. PubMed ID: 4996757
    [No Abstract]   [Full Text] [Related]  

  • 33. QUANTITATIVE ASPECTS OF LABILE DIABETES.
    MOLNAR GD; GASTINEAU CF; ROSEVEAR JW; MOXNESS KE
    Diabetes; 1965 May; 14():279-88. PubMed ID: 14280369
    [No Abstract]   [Full Text] [Related]  

  • 34. [Activity of varous prolonged action insulins in diabetes in children].
    Nowak S; Planeta-Malecka I; Margolis A; Olszowska L; Krzemieniowa I
    Pediatr Pol; 1968 May; 43(5):585-92. PubMed ID: 4875943
    [No Abstract]   [Full Text] [Related]  

  • 35. Human ultralente insulin.
    Holman RR; Steemson J; Darling P; Reeves WG; Turner RC
    Br Med J (Clin Res Ed); 1984 Mar; 288(6418):665-8. PubMed ID: 6421424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [New formulation with improved pharmacokinetics].
    Walter M
    MMW Fortschr Med; 2015 Feb; 157(3):69. PubMed ID: 25743680
    [No Abstract]   [Full Text] [Related]  

  • 37. Management of juvenile diabetes mellitus: usefulness of 24-hour fractional quantitative urine glucose.
    Forman BH; Goldstein PS; Genel M
    Pediatrics; 1974 Feb; 53(2):257-63. PubMed ID: 4812010
    [No Abstract]   [Full Text] [Related]  

  • 38. Insulin degludec, a long-acting once-daily basal analogue for type 1 and type 2 diabetes mellitus.
    Berard L; MacNeill G
    Can J Diabetes; 2015 Feb; 39(1):4-9. PubMed ID: 25065475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of ultralente insulin in cats with diabetes mellitus.
    Nelson RW; Feldman EC; DeVries SE
    J Am Vet Med Assoc; 1992 Jun; 200(12):1828-9. PubMed ID: 1639685
    [No Abstract]   [Full Text] [Related]  

  • 40. [Insulin requirements of patients with initial manifestations and decompensation of diabetes mellitus].
    Martynova MI; Sapelkina LV; Piliutik VF; Terent'eva EA; Doroshenko EO
    Pediatriia; 1989; (11):14-6. PubMed ID: 2691978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.